| Acquired by | Charles River Laboratories International |
| Price | $12.4M |
| Date | 9/08 |
| Website | moleculartherapeu... |
| Category | BioTech |
| Phone | 734.259.4574 |
| al@molecularthera... | |
| Employees |
Molecular Therapeutics, Inc. (MRx) is a privately held biotechnology holding company that focuses on in-licensing promising pharmaceutical and medical device technologies in the late preclinical development phase and conducts proof-of-principle clinical (phase II) studies on a virtual basis for eventual corporate partnership and commercialization.
